OBJECTIVE: The study objective was to examine whether hospitalization for pneumonia is associated with functional decline, cognitive impairment, and depression, and to compare this impairment with that seen after known disabling conditions, such as myocardial infarction or stroke. METHODS: We used data from a prospective cohort of 1434 adults aged more than 50 years who survived 1711 hospitalizations for pneumonia, myocardial infarction, or stroke drawn from the Health and Retirement Study (1998-2010). Main outcome measures included the number of Activities and Instrumental Activities of Daily Living requiring assistance and the presence of cognitive impairment and substantial depressive symptoms. RESULTS: Hospitalization for pneumonia was associated with 1.01 new impairments in Activities and Instrumental Activities of Daily Living (95% confidence interval [CI], 0.71-1.32) among patients without baseline functional impairment and 0.99 new impairments in Activities and Instrumental Activities of Daily Living (95% CI, 0.57-1.41) among those with mild-to-moderate baseline limitations, as well as moderate-to-severe cognitive impairment (odds ratio, 2.46; 95% CI, 1.60-3.79) and substantial depressive symptoms (odds ratio, 1.63; 95% CI, 1.06-2.51). Patients without baseline functional impairment who survived pneumonia hospitalization had more subsequent impairments in Activities and Instrumental Activities of Daily Living than those who survived myocardial infarction hospitalization. There were no significant differences in subsequent moderate-to-severe cognitive impairment or substantial depressive symptoms between patients who survived myocardial infarction or stroke and those who survived pneumonia. CONCLUSIONS: Hospitalization for pneumonia in older adults is associated with subsequent functional and cognitive impairment. Improved pneumonia prevention and interventions to ameliorate adverse sequelae during and after hospitalization may improve outcomes.
OBJECTIVE: The study objective was to examine whether hospitalization for pneumonia is associated with functional decline, cognitive impairment, and depression, and to compare this impairment with that seen after known disabling conditions, such as myocardial infarction or stroke. METHODS: We used data from a prospective cohort of 1434 adults aged more than 50 years who survived 1711 hospitalizations for pneumonia, myocardial infarction, or stroke drawn from the Health and Retirement Study (1998-2010). Main outcome measures included the number of Activities and Instrumental Activities of Daily Living requiring assistance and the presence of cognitive impairment and substantial depressive symptoms. RESULTS: Hospitalization for pneumonia was associated with 1.01 new impairments in Activities and Instrumental Activities of Daily Living (95% confidence interval [CI], 0.71-1.32) among patients without baseline functional impairment and 0.99 new impairments in Activities and Instrumental Activities of Daily Living (95% CI, 0.57-1.41) among those with mild-to-moderate baseline limitations, as well as moderate-to-severe cognitive impairment (odds ratio, 2.46; 95% CI, 1.60-3.79) and substantial depressive symptoms (odds ratio, 1.63; 95% CI, 1.06-2.51). Patients without baseline functional impairment who survived pneumonia hospitalization had more subsequent impairments in Activities and Instrumental Activities of Daily Living than those who survived myocardial infarction hospitalization. There were no significant differences in subsequent moderate-to-severe cognitive impairment or substantial depressive symptoms between patients who survived myocardial infarction or stroke and those who survived pneumonia. CONCLUSIONS: Hospitalization for pneumonia in older adults is associated with subsequent functional and cognitive impairment. Improved pneumonia prevention and interventions to ameliorate adverse sequelae during and after hospitalization may improve outcomes.
Authors: Cindy Parks Thomas; Marian Ryan; John D Chapman; William B Stason; Christopher P Tompkins; Jose A Suaya; Daniel Polsky; David M Mannino; Donald S Shepard Journal: Chest Date: 2012-10 Impact factor: 9.410
Authors: Peter C Wroe; Jonathan A Finkelstein; G Thomas Ray; Jeffrey A Linder; Kristen M Johnson; Sheryl Rifas-Shiman; Matthew R Moore; Susan S Huang Journal: J Infect Dis Date: 2012-03-23 Impact factor: 5.226
Authors: K M Langa; M E Chernew; M U Kabeto; A R Herzog; M B Ofstedal; R J Willis; R B Wallace; L M Mucha; W L Straus; A M Fendrick Journal: J Gen Intern Med Date: 2001-11 Impact factor: 5.128
Authors: Kristine Yaffe; Patrick Fox; Robert Newcomer; Laura Sands; Karla Lindquist; Kyle Dane; Kenneth E Covinsky Journal: JAMA Date: 2002-04-24 Impact factor: 56.272
Authors: Vladimir Kaplan; Gilles Clermont; Martin F Griffin; Jan Kasal; R Scott Watson; Walter T Linde-Zwirble; Derek C Angus Journal: Arch Intern Med Date: 2003-02-10
Authors: Dimitry S Davydow; Wayne J Katon; Elizabeth H B Lin; Paul Ciechanowski; Evette Ludman; Malia Oliver; Michael Von Korff Journal: J Gen Intern Med Date: 2013-01-17 Impact factor: 5.128
Authors: Laura C Feemster; Colin R Cooke; Gordon D Rubenfeld; Catherine L Hough; William J Ehlenbach; David H Au; Vincent S Fan Journal: Ann Am Thorac Soc Date: 2015-01
Authors: Dimitry S Davydow; Kara Zivin; Wayne J Katon; Gregory M Pontone; Lydia Chwastiak; Kenneth M Langa; Theodore J Iwashyna Journal: J Gen Intern Med Date: 2014-10 Impact factor: 5.128
Authors: Dimitry S Davydow; Deborah A Levine; Kara Zivin; Wayne J Katon; Kenneth M Langa Journal: Psychosom Med Date: 2015 Feb-Mar Impact factor: 4.312
Authors: Timothy D Girard; Wesley H Self; Kathryn M Edwards; Carlos G Grijalva; Yuwei Zhu; Derek J Williams; Seema Jain; James C Jackson Journal: J Gen Intern Med Date: 2018-01-26 Impact factor: 5.128